Hrt Financial LP China Pharma Holdings, Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.21 - $0.39 $3,619 - $6,722	-17,236 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.34 - $0.5 $15,529 - $22,837	-45,675 Reduced 72.6%	17,236 $6,000
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.68 $90,213 - $149,623	-220,034 Reduced 77.77%	62,911 $30,000
Q3 2021 Nov 15, 2021	BUY	$0.53 - $0.91 $11,674 - $20,044	22,027 Added 8.44%	282,945 $158,000
Q2 2021 Aug 16, 2021	SELL	$0.57 - $0.99 $4,110 - $7,138	-7,211 Reduced 2.69%	260,918 $188,000
Q1 2021 May 17, 2021	BUY	$0.49 - $1.28 $122,424 - $319,801	249,845 Added 1366.47%	268,129 $225,000
Q4 2020 Feb 16, 2021	SELL	$0.36 - $0.55 $47,545 - $72,639	-132,071 Reduced 87.84%	18,284 $8,000
Q3 2020 Nov 13, 2020	BUY	$0.33 - $0.62 $29,995 - $56,354	90,894 Added 152.86%	150,355 $54,000
Q2 2020 Aug 14, 2020	BUY	$0.39 - $0.71 $23,189 - $42,217	59,461 New	59,461 $39,000

Ticker CPHI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 50,449,700
Market Cap $12.1M
Description
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. It...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.